Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, other inflammatory diseases, immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes; and cardiovascular and established prescription products. It also supplies poliomyelitis, pertussis, and hib pediatric vaccines; and influenza, adult booster, meningitis, and travel and endemic vaccines. In addition, the company offers allergy, cough and cold, pain, liver care, physical and mental wellness, probiotics, digestive, and nutritional products; and other products, such as daily body lotions, anti-itch products, moisturizing and soothing lotions, and body and foot creams, as well as powders for eczema. Further, it has various pharmaceutical products and vaccines in development stage. Sanofi has collaboration agreement with GlaxoSmithKline to develop a recombinant Covid-19 vaccine; and a research collaboration with Stanford University School of Medicine to advance the understanding of immunology and inflammation through open scientific exchange. It also has a collaboration and license option agreement with Prellis Biologics, Inc. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• [06/24/2025 07:29 PDT] SNY Expected to Trade Up After Bullish Patterns Develop
• [06/16/2025 10:29 PDT] SNY SqueezeTrigger Price is $0.00. There is $0 That Short Sellers Still Need To Cover.
• [06/16/2025 07:11 PDT] SNY Expected to Trade Up After Bullish Patterns Develop
• [06/12/2025 10:29 PDT] SNY SqueezeTrigger Price is $0.00. There is $0 That Short Sellers Still Need To Cover.
• [06/10/2025 12:42 PDT] SNY SqueezeTrigger Price is $0.00. There is $0 That Short Sellers Still Need To Cover.
• [06/10/2025 06:56 PDT] SNY Expected to Trade Up After Bullish Patterns Develop
• [06/05/2025 11:45 PDT] SNY SqueezeTrigger Price is $0.00. There is $0 That Short Sellers Still Need To Cover.
• [06/03/2025 07:14 PDT] SNY Expected to Trade Down After Bearish Patterns Develop
• [05/21/2025 11:07 PDT] Sanofi (NASDAQ:SNY), Up By 100% ($50.14) After BUYINS.NET SqueezeTrigger Report Released on Thursday, May 15th 2025 at a Price of $50.135.
• [05/21/2025 11:07 PDT] Sanofi (NASDAQ:SNY), Up By 100% ($50.08) After BUYINS.NET SqueezeTrigger Report Released on Monday, May 12th 2025 at a Price of $50.08.
• [05/20/2025 07:37 PDT] SNY Expected to Trade Up After Bullish Patterns Develop
• [05/15/2025 12:04 PDT] SNY SqueezeTrigger Price is $0.00. There is $0 That Short Sellers Still Need To Cover.
• [05/15/2025 06:58 PDT] SNY Expected to Trade Down Short Term
• [05/13/2025 07:10 PDT] SNY Expected to Trade Down After Bearish Patterns Develop
• [05/12/2025 08:16 PDT] SNY SqueezeTrigger Price is $0.00. There is $0 That Short Sellers Still Need To Cover.
• [05/12/2025 07:19 PDT] SNY Expected to Trade Down Short Term
• [05/05/2025 07:20 PDT] SNY Expected to Trade Up After Bullish Patterns Develop
• [04/30/2025 10:29 PDT] Sanofi (NASDAQ:SNY), Up By 100% ($50.61) After BUYINS.NET SqueezeTrigger Report Released on Friday, April 11th 2025 at a Price of $50.61.